Literature DB >> 7976236

Acute cerebellar ataxia after immunisation with recombinant hepatitis B vaccine.

F Deisenhammer1, P Pohl, S Bösch, C Schmidauer.   

Abstract

We report one woman with acute cerebellar ataxia (ACA), a well-defined clinical syndrome, which occurred 10 days after the second vaccination with recombinant hepatitis B vaccine. The patient had no previous symptoms or signs of neurological disease and there was no evidence of neurologic disease in the family history. Within nine months the symptoms remitted completely according to other reports of ACA. As there was a close temporal connection and no noticeable other cause we assume a causal link between the vaccination and the disease. As far as we known this is the first case of ACA after hepatitis B vaccination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7976236     DOI: 10.1111/j.1600-0404.1994.tb02667.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  2 in total

1.  Hepatitis B vaccine and neurotoxicity.

Authors:  M Pirmohamed; P Winstanley
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

2.  Cerebellar ataxia and neuropathy as presenting features of hepatitis-B related cirrhosis and portal hypertension.

Authors:  Arunmozhi Elavarasi; Deepa Dash; Manjari Tripathi; Rohit Bhatia
Journal:  BMJ Case Rep       Date:  2017-10-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.